Phase I/II trial of Epratuzumab (humanized anti-CD22 antibody) in non-Hodgkin's lymphoma (NHL)

1 Citations

Search this article

Journal

  • Blood

    Blood 100 358a-, 2002

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1571698599888466176
  • NII Article ID
    10011236196
  • NII Book ID
    AA00567156
  • Data Source
    • CiNii Articles

Report a problem

Back to top